133 related articles for article (PubMed ID: 38458075)
1. Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes.
Garcia-Loza I; Perna-Barrull D; Aguilera E; Almenara-Fuentes L; Gomez-Muñoz L; Greco D; Vila M; Salvado M; Mancera-Arteu M; Olszowy MW; Petriz J; Dalmases M; Rodriguez-Vidal S; Barneda-Zahonero B; Vives-Pi M
J Autoimmun; 2024 May; 145():103196. PubMed ID: 38458075
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry.
Rodriguez-Fernandez S; Pujol-Autonell I; Brianso F; Perna-Barrull D; Cano-Sarabia M; Garcia-Jimeno S; Villalba A; Sanchez A; Aguilera E; Vazquez F; Verdaguer J; Maspoch D; Vives-Pi M
Front Immunol; 2018; 9():253. PubMed ID: 29491866
[TBL] [Abstract][Full Text] [Related]
3. Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential.
Rodriguez-Fernandez S; Murillo M; Villalba A; Perna-Barrull D; Cano-Sarabia M; Gomez-Muñoz L; Aguilera E; Maspoch D; Vazquez F; Bel J; Vives-Pi M
Front Immunol; 2019; 10():2811. PubMed ID: 31849983
[TBL] [Abstract][Full Text] [Related]
4. Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes.
Pujol-Autonell I; Serracant-Prat A; Cano-Sarabia M; Ampudia RM; Rodriguez-Fernandez S; Sanchez A; Izquierdo C; Stratmann T; Puig-Domingo M; Maspoch D; Verdaguer J; Vives-Pi M
PLoS One; 2015; 10(6):e0127057. PubMed ID: 26039878
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes.
Villalba A; Rodriguez-Fernandez S; Ampudia RM; Cano-Sarabia M; Perna-Barrull D; Bertran-Cobo C; Ehrenberg C; Maspoch D; Vives-Pi M
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):77-83. PubMed ID: 31852325
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T Cells Induced by Single-Peptide Liposome Immunotherapy Suppress Islet-Specific T Cell Responses to Multiple Antigens and Protect from Autoimmune Diabetes.
Bergot AS; Buckle I; Cikaluru S; Naranjo JL; Wright CM; Zheng G; Talekar M; Hamilton-Williams EE; Thomas R
J Immunol; 2020 Apr; 204(7):1787-1797. PubMed ID: 32111734
[TBL] [Abstract][Full Text] [Related]
7. Liposome-based immunotherapy against autoimmune diseases: therapeutic effect on multiple sclerosis.
Pujol-Autonell I; Mansilla MJ; Rodriguez-Fernandez S; Cano-Sarabia M; Navarro-Barriuso J; Ampudia RM; Rius A; Garcia-Jimeno S; Perna-Barrull D; Martinez-Caceres E; Maspoch D; Vives-Pi M
Nanomedicine (Lond); 2017 Jun; 12(11):1231-1242. PubMed ID: 28593827
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes.
Marin-Gallen S; Clemente-Casares X; Planas R; Pujol-Autonell I; Carrascal J; Carrillo J; Ampudia R; Verdaguer J; Pujol-Borrell R; Borràs FE; Vives-Pi M
Clin Exp Immunol; 2010 May; 160(2):207-14. PubMed ID: 20030670
[TBL] [Abstract][Full Text] [Related]
9. THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro.
Shiratori H; Feinweber C; Luckhardt S; Linke B; Resch E; Geisslinger G; Weigert A; Parnham MJ
Mol Immunol; 2017 Aug; 88():58-68. PubMed ID: 28600970
[TBL] [Abstract][Full Text] [Related]
10. NF-kappa B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages.
Sen P; Bhattacharyya S; Wallet M; Wong CP; Poligone B; Sen M; Baldwin AS; Tisch R
J Immunol; 2003 Feb; 170(4):1770-80. PubMed ID: 12574341
[TBL] [Abstract][Full Text] [Related]
11. An increased adjuvanticity of liposomes by the inclusion of phosphatidylserine in immunization with surface-coupled liposomal antigen.
Mori M; Nishida M; Maekawa N; Yamamura H; Tanaka Y; Kasai M; Taneichi M; Uchida T
Int Arch Allergy Immunol; 2005 Jan; 136(1):83-9. PubMed ID: 15591816
[TBL] [Abstract][Full Text] [Related]
12. Allostimulatory activity as a criterion of the functional phenotype of human macrophages.
Yankovskaya AA; Shevela EY; Sakhno LV; Tikhonova MA; Dome AS; Ostanin AA; Chernykh ER
Hum Immunol; 2019 Oct; 80(10):890-896. PubMed ID: 31447056
[TBL] [Abstract][Full Text] [Related]
13. Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.
Krishnamurthy B; Selck C; Chee J; Jhala G; Kay TW
J Autoimmun; 2016 Jul; 71():35-43. PubMed ID: 27083395
[TBL] [Abstract][Full Text] [Related]
14. Diabetes-prone NOD mice show an expanded subpopulation of mature circulating monocytes, which preferentially develop into macrophage-like cells in vitro.
Nikolic T; Bouma G; Drexhage HA; Leenen PJ
J Leukoc Biol; 2005 Jul; 78(1):70-9. PubMed ID: 15788439
[TBL] [Abstract][Full Text] [Related]
15. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens.
Almenara-Fuentes L; Rodriguez-Fernandez S; Rosell-Mases E; Kachler K; You A; Salvado M; Andreev D; Steffen U; Bang H; Bozec A; Schett G; Le Panse R; Verdaguer J; Dalmases M; Rodriguez-Vidal S; Barneda-Zahonero B; Vives-Pi M
Nanomedicine; 2023 Feb; 48():102635. PubMed ID: 36481472
[TBL] [Abstract][Full Text] [Related]
16. Involvement of splenic marginal zone macrophages in the recognition of systemically administered phosphatidylserine-coated liposomes in mice.
Tada R; Nagao K; Tanaka R; Yamada S; Watanabe A; Negishi Y
Int Immunopharmacol; 2022 Nov; 112():109209. PubMed ID: 36084540
[TBL] [Abstract][Full Text] [Related]
17. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3).
Fadok VA; Warner ML; Bratton DL; Henson PM
J Immunol; 1998 Dec; 161(11):6250-7. PubMed ID: 9834113
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylserine and/or Sialic Acid Modified Liposomes Increase Uptake by Tumor-associated Macrophages and Enhance the Anti-tumor Effect.
Xu Z; Li J; Yan N; Liu X; Deng Y; Song Y
AAPS PharmSciTech; 2024 Jun; 25(5):125. PubMed ID: 38834759
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study.
Nikolic T; Geutskens SB; van Rooijen N; Drexhage HA; Leenen PJ
Lab Invest; 2005 Apr; 85(4):487-501. PubMed ID: 15654358
[TBL] [Abstract][Full Text] [Related]
20. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
Front Immunol; 2018; 9():290. PubMed ID: 29503651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
